- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 595924, 15 pages
A Network-Based Systematic Study for the Mechanism of the Treatment of Zhengs Related to Cough Variant Asthma
1Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China
2Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
3China-Japan Friendship Hospital, Beijing 100029, China
Received 8 July 2013; Revised 10 September 2013; Accepted 12 September 2013
Academic Editor: Shao Li
Copyright © 2013 Di Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Traditional Chinese medicine (TCM) has shown significant efficacy in the treatment of cough variant asthma (CVA), a special type of asthma. However, there is shortage of explanations for relevant mechanism of treatment. As Zhengs differentiation is a critical concept in TCM, it is necessary to explain the mechanism of treatment of Zhengs. Based on TCM clinical cases, this study illustrated the mechanism of the treatment of three remarkably relevant Zhengs for CVA: “FengXieFanFei,” “FeiQiShiXuan”, and “QiDaoLuanJi.” To achieve this goal, five steps were carried out: (1) determining feature Zhengs and corresponding key herbs of CVA by analyses of clinical cases; (2) finding out potential targets of the key herbs and clustering them based on their functional annotations; (3) constructing an ingredient-herb network and an ingredient network; (4) identifying modules of the ingredient network; (5) illustrating the mechanism of the treatment by further mining the latent biological implications within each module. The systematic study reveals that the treatment of “FengXieFanFei,” “FeiQiShiXuan,” and “QiDaoLuanJi” has effects on the regulation of multiple bioprocesses by herbs containing different ingredients with functions of steroid metabolism regulation, airway inflammation, and ion conduction and transportation. This network-based systematic study will be a good way to boost the scientific understanding of mechanism of the treatment of Zhengs.
Traditional Chinese medicine (TCM), as a system of ancient medical practice which differs in substance, methodology, and philosophy from modern medicine, involves a broad range of empirical testing and refinement and plays an important role in the health maintenance for people. During the long history of TCM clinical practices, much treatment experience for a myriad of diseases has been accumulated . The clinical cases of TCM, especially those from experienced TCM doctors, are precious sources for the understanding and development of TCM.
Doctors diagnose whether a patient is suffering from certain types of diseases or not based on a comprehensive analysis of the patient’s symptoms. In the field of TCM, it is especially important to identify patients’ Zhengs based on the four diagnostic methods, which include inspection, listening and smelling, inquiry, and pulse taking. According to Zhengs, TCM practitioners will prescribe proper formulas to patients in order to heal their disorders [2, 3]. Herbal medicines, a powerful tool of TCM, can heal different kinds of Zhengs by combinations [4–6]. Although there are substantial records of TCM clinical cases and corresponding analyses of the clinical information [7–9], there is still shortage of scientific explanations for corresponding mechanism.
With the development of bioinformatics and system biology [10–12], it is possible to analyze the molecular mechanism of drugs. Some system biology tools, with extremely high efficiency and molecular level representation, have been invented (e.g., MetaDrug (http://www.genego.com/)). They are widely used for the understanding of the complex functions of compounds [13–15]. With the help of system biology tools, herbal functions and the mechanism of treatment of Zhengs can be interpreted in some degree.
Cough variant asthma (CVA), a type of asthma with main symptom of a dry, nonproductive cough [16–18], is affecting many people’s health. It is sometimes called chronic cough to describe a cough that has lasted longer than six to eight weeks. Together with lung disease and other symptoms such as tachycardia and dyspnea [19–22], CVA is one major health burden in the area of respiratory medicine. In the field of TCM, CVA is usually related with the Zheng of “FengXie (wind-evil)” and is named as “FengKe” in Chinese.
Although TCM has shown remarkable curative effects for CVA, the latent mechanism is still unknown. Current studies on TCM have provided few insights into the biological mechanism. The obscurity of the mechanism will hinder the development and clinical popularizing of TCM theory. A systematic study on the mechanism of the treatment of TCM Zhengs from the aspects of herb ingredients, ingredient targets, and their functions, as well as the complex relationships among them is extremely necessary. Besides, explanations for the mechanism of the treatment of CVA-related Zhengs can help us validate the reasonability of TCM theory and develop a deep understanding of the mechanism which is beneficial to new herbal medicine design. This study tried to illustrate the biological mechanism of the treatment of Zhengs related with CVA by analyzing the clinical cases.
2. Materials and Methods
We have identified the potential mechanism of the herbs for the treatment of three distinguished Zhengs of CVA by a network-based systematic study (as shown in Figure 1) of the TCM clinical cases. Our approach proceeds as follows.(1)Determine feature Zhengs and corresponding key herbs of CVA by analyzing clinical cases.(2)Find out potential targets of key herbs and cluster them based on their functional annotations. (3)Construct an ingredient-herb network and an ingredient network to study the relationship between ingredients and herbs.(4)Identify modules in the ingredient network.(5)Illustrate the mechanism of the treatment by mining the latent biological implications (pathways and GOs ) within each module.
2.1. Analysis of TCM Clinical Cases
2.1.1. Identification of Feature Zhengs of CVA
The information of the clinical cases was collected from June 2009 to July 2012, by the Famous TCM Doctor Inheritance Studio of Chao Enxiang, who has engaged in medical work for more than forty years and has accumulated many successful experiences of treating CVA [24, 25], and the data were exported from the Traditional Chinese Medicine Inheritance Support Plat . These cases were recorded in standard format, so it is convenient to do analysis about them. These clinical cases contain the information of Zhengs, disease name, the principle and method of therapy, herbal formulae, patient’s age, and gender, and so on. By statistical analyses of the clinical cases, we have identified some highly related Zhengs for CVA. These Zhengs are distinguished from others for they occur remarkably more times than the others in the clinical cases. These Zhengs, which represent the main feature of CVA, were defined as feature Zhengs of CVA.
2.1.2. Identification of the Key Herbs
The clinical cases list the herbs which constitute the formulas. It is easy to find that similar Zhengs are treated by similar formulas as discussed in [27, 28]. Although formulas of patients with the same Zhengs can vary with individuals’ conditions, there are always several herbs prescribed changelessly for the same Zhengs. The clinical cases from Professor Chao included 2414 cases and 948 records of formulas. These cases provided abundant information about the herb combination laws and treatment rules. As it is difficult to elaborate the mechanism of the treatment of Zhengs directly, we tried to illustrate the latent mechanism by finding the functions of the herbs alternatively. The conditional probability of an herb appeared in the cases given certain Zheng can be used to represent the correlation degree between an herb and a Zheng. In our study, more than one Zheng was identified as feature Zhengs; the conditional probability given these Zhengs is as below: where represents an herb, represents the set of feature Zhengs, represents how many times herb and Zheng appear in the same case, and is the times Zheng appears in the clinical cases. represents the probability of an herb that appeared given the feature Zhengs.
Herbs with high conditional probability are more related to the feature Zhengs. However, as TCM pays attention to the rules of composition, it is not suitable to consider each herb separately without consideration of their combination rules [29–31]. Apriori’s algorithm  was used here to find out core formulas, and the minimum support was set at 0.4. Then herbs with high conditional probability and appearing in the core formulas at the same time were defined as the key herbs which were highly related to the feature Zhengs. By analyzing the mechanism of the key herbs, it will help to understand the mechanism of the treatment of feature Zhengs.
2.2. Potential Targets of Key Herbs
2.2.1. Finding Out the Potential Targets
A drug target is a key molecule involved in particular metabolic or signaling pathways which are specific to a disease condition or pathology [33–35]. In order to find out the bioprocesses that may be affected by the herbs, we need to find out the potential targets of key herbs. If some targets are targeted by most of the key herbs, it is probable that these targets play key roles in the treatment of the feature Zhengs.
To find out the potential targets of key herbs, we need to seek out the compounds of each herb at first. The targets of the ingredients of an herb were considered as the targets of this herb. In our study, we used MetaDrug, which is a system biology tool developed by the Gene GO company [14, 15], to find the potential targets of each compound. This tool uses the known targets of similar compounds to predict the possible targets of a compound. The similarity is referred to as the chemical structure similarity defined by Tanimoto’s coefficient . In order to achieve relatively reliable results, we set the lower and upper values of the coefficient to 0.9 and 1.0 to do the similarity search.
2.2.2. Clustering the Potential Targets Based on Functions
Because of the great number of compounds of an herb and the multiple targets of each compound, the total number of the targets of all the key herbs is substantial. The great amount of targets makes it difficult to understand the biological meaning, so we clustered the targets according to their functional annotations. The clustering was done by DAVID , a tool widely used in the studies about genes or proteins. Targets in the same cluster share similar functional annotations, and different clusters represent different functions.
2.3. Network-Based Analysis
2.3.1. Herb-Ingredient Network
An herb-ingredient network is a bipartite network constructed by simply connecting an herb and its ingredients together. It can shed light on the relationship of different herbs’ ingredients and supply some latent lines of evidence for the combination rules of herbs at the same time.
2.3.2. Ingredient Network
We constructed an ingredient network based on the shared functions of ingredients.(1) Ingredient functions.
Since an ingredient achieves its effects by acting on certain targets, functions of an ingredient can be derived by the functions of its targets. However, one ingredient can have effects on multiple targets of which the functions are complex. We obtained the detailed functions of an ingredient by enrichment analyses of its targets in respect to GO processes, GO molecular functions, GO localizations, and pathways. The enrichment results were gotten from MetaDrug with a value less than , and all of the four aspect functions are in standardized items. At last, each ingredient was assigned a standardized functional item set.(2) Ingredient network construction.
According to the ingredient functions gotten from enrichment analyses of targets, the relationship between two ingredients can be represented by the intersection of their functional item sets. The weight of an edge on the ingredient network is defined as below: where , are two ingredients; represents four different enriched aspects: GO processes, GO molecular functions, GO localizations, pathways}; represents the set of enriched functions of in the aspect of ; represents the size of a set; and , represent intersection and union of two sets as usual.
We constructed an ingredient network in our study by only considering edges with a weight larger than the threshold of 0.2 and with value (Fisher’s exact test) less than 0.01. Besides, we also assigned the intersection of two sets of functional items: to each edge as its functional implications for further analysis, where represents the united set of functional items of four aspects.
2.3.3. Network Visualization
All of the networks were visualized by Cytoscape , a widely used network visualization tool. Targets, ingredients, and herbs in the networks are represented by nodes, and interactions are represented by edges.
2.4. Modules of Ingredient Network
To figure out the latent mechanism, just finding out functional relationship between ingredients by a network is not enough. We should also find out whether these ingredients collaborate with each other to achieve certain main functions or not. Modules [38, 39] are densely related parts of a network, so modules in the ingredient networks can stand for the functional related ingredients. We used MCODE , an effective network module identification plugin of Cytoscape, to identify the modules from the ingredient network.
2.5. Module Functions
Modules of the ingredient network can suggest which ingredients have similar functions. To explore the biological meaning hidden in each module, we employed the functional implications assigned to the edges, as discussed in Section 2.3.2. By counting the functional items of edges in each module, we got the frequent items whose frequencies were larger than half of the biggest counts of all items within a module to reveal the main functions of the module.
3. Results and Discussion
For thousands of years, TCM holds a great promise for medical treatments in China and now is considered as a complementary medical system in many Western countries . Despite the fact that many positive outcomes have been observed in TCM clinical cases, the underlying mechanism of the treatment of Zhengs is unclear. An herbal formula usually incorporates several herbs which are chosen based on the patients’ Zhengs, so we can catch sight of the underlying Zheng treatment mechanism by analyzing the related herbs indirectly. In this study, we applied our method to the clinical cases of Professor Chao to find out the biological mechanism.
3.1. Feature Zhengs Derived from Clinical Cases
We collected 2414 clinical cases of CVA-related diseases, and the final statistics showed that among all of the 133 different Zhengs recorded, “FengXieFanFei (wind-evil invading lung),” “FeiQiShiXuan (lung Qi obstruction),” and “QiDaoLuanJi (twin acute airway)” were three most frequent CVA-related Zhengs. As shown in Figure 2, these Zhengs were not only frequent, but also possessed an apparent advantage over all other Zhengs. These three Zhengs occupied 67% of all the Zhengs recorded in the clinical cases while the other 130 Zhengs occupied 33% of the cases. This manifested that most of the CVA cases were related to these three Zhengs. Consequently, “FeiQiShiXuan,” “QiDaoLuanJi,” “FengXieFanFei,” three most typical Zhengs for CVA, were determined as the feature Zhengs of these CVA-related clinical cases.
3.2. Key Herbs of the Feature Zhengs
3.2.1. Conditional Probability of Each Herb Given the Feature Zhengs
As shown in Figure 3, the probabilities of the first 11 herbs—Semen Armeniacae amarum (SAA), Lumbricus (Lum), Perilla frutescens Leaf (PFL), Periostracum cicadae (PC), Achene of Great Burdock (AGB), Aster tataricus (AT), Fried Eriobotrya japonica (FEJ), Schisandra chinensis (SC), Perilla frutescens seed (PFS), Raw Licorice (RL), and Fried Herba ephedrae (FHE) were larger than 0.7. The probabilities of these 11 herbs are apparently higher than other herbs for the treatment of “FeiQiShiXuan,” “FengXieFanFei,” and “QiDaoLuanJi”; they must play key roles in the treatment of these feature Zhengs.
3.2.2. Core Formula
Furthermore, we applied Apriori’s algorithm to determine the frequent herb combinations as the core formula for the treatment of feature Zhengs. The combinations found out by the algorithm (the support rate was set at 0.4) were SAA, Lum, PFL, PC, AGB, AT, FEJ, SC, PFS, RL, and FHE.
The result showed that these 11 herbs were frequently prescribed together to heal CVA. Considering the high conditional probability of the 11 herbs as discussed in Section 3.2.1 and their frequent combination, these two results testified that not only do the 11 herbs play key roles by isolation analysis, but also they can combine with each other to achieve therapeutic effects. It is reasonable to define these 11 herbs as the key herbs of the feature Zhengs. There are also many studies that prove the effectiveness of the 11 herbs for the treatment of CVA [42–48], and nine of them are the ingredients of “Suhuangzhike” granules, a Chinese patent medicine which has shown significant clinical effects [49–51].
3.3. Potential Targets of Key Herbs
3.3.1. Targets of the Herbs
There were 306 compounds collected for the 11 key herbs. The potential targets for the compounds were obtained by the targets prediction function of MetaDrug. The potential targets of an herb were considered as the sum of the targets of its compounds. The number of compounds and potential targets for each herb is listed in Table 1. This testifies the multicompounds and multitargets characteristics of Chinese herbs. There are 954 different targets for all 11 key herbs, and 372 of them are the targets of more than 7 compounds. To make our study more reliable and to show that Chinese medicine achieve the therapeutic effects by combination of compounds, we used the 372 targets which were targeted by more than 7 compounds for the following analyses.
3.3.2. Target-Compound Network
We got the interaction networks of compounds and their potential targets as shown in Figure 4. As we can see from the network, multiple compounds act on the same targets. This is different from Western medicine which usually employs only one compound to act on one certain target.
3.3.3. Clustering Targets Based on Functional Annotations
However, the number of targets is so big and the promiscuity of the targets restrains the understanding of the mechanism. To make clear the main functions of the key herbs, we clustered these targets by the functional annotations clustering function of DAVID. We got 18 clusters in total, and the main clusters are shown in Table 2. Clusters 1 to 3 are three biggest clusters; Clusters 4 and 5 are the clusters with OMIM  genes of asthma and cough, two similar diseases of CVA.
To find out the mechanism of the herbs, functions of these targets are of crucial roles. As the clustering process is based on functional annotations of each gene, different clusters must correspond to different functions. The functions of the biggest clusters correspond to the main functions of the key herbs. The genes in Cluster 1 are connected with hormone stimulus. Activated estrogen receptors (ER, Cluster 1) via ERα or ERβ stimulate NO production in airway epithelium; estrogen-induced NO and its impairment may contribute to altered bronchodilator in women with asthma . Peroxisome proliferator-activated receptor γ (PPARγ, Cluster 1) ligands, such as rosiglitazone and pioglitazone, inhibit proliferation and inflammatory cytokine production from airway smooth muscles through a PPARγ-independent mechanism . The genes in Cluster 2 are associated with cellular metabolic process. Mitogen-activated protein kinase-1 (MAPK1, Cluster 2) controls a vast array of physiological processes. Inflammatory cytokines and environmental stresses may activate p38 MAPKs, which contributes to diseases like asthma and autoimmunity . Pim kinases are a family of serine/threonine kinases that are induced by cytokines and involved in allergy and asthma. The inhibition of Pim1 kinase (Cluster 2) effectively prevents the development of airway hyperresponsiveness, airway inflammation, and cytokine production in allergen-sensitized and allergen-challenged mice . Most studies of chronic cough or bronchial asthma deal with IgE responsiveness. Different serum IgG1, IgG2, and IgG3 (Immunoglobulin, Cluster 3) levels together with different numbers of peripheral blood eosinophil and CD8 lymphocytes represent different pathways of immune regulation of bronchial asthma .
The three biggest clusters are all related to the treatment of asthma or cough by regulating the hormone stimulus, airway inflammation, and immune regulations. Except for these three clusters, two clusters (Clusters 4, 5) have OMIM genes (Genes IDs: 718, 1080) of asthma or cough in the cluster, and we define the two clusters as disease-related target clusters. The genes in Cluster 4 are mainly related to complement system. The activation of the complement system could have a role in treating cough by promoting inflammation and enhancing airway hyperresponsiveness. C5a is usually elevated at the site of inflammation in patients with asthma . The genes in Cluster 5 are related to transport function across cell membrane. ATP-binding cassette (ABC) transporters are a family of transmembrane proteins which can transport numerous substrates across biological membranes in an energy-dependent pattern. Many ABC transporters such as P-glycoprotein (P-gp), multidrug resistance-associated protein 1 (MRP1), and breast cancer resistance protein (BCRP) are highly expressed in bronchial epithelium. These three ABC transporters are well known to play an important role in lung functioning. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene can cause cystic fibrosis. The role of altered function of ABC transporters in asthma has hardly been investigated so far .
The multiple functions of the targets prove that TCM aims not only to antagonize specific pathogenic targets, but also to correct maladjustments and restore the self-regulatory ability of the body.
3.4. Herb-Ingredient Network
To understand the mechanism of herb combinations, it is necessary to know whether ingredients of an herb have similar functions or different herbs share similar compositions. The herb-ingredient network, as shown in Figure 5, in which different colors represent different functions, provides a way to make clear the composition characteristics of herbs.
It is obvious to see from the herb-ingredient network that different key herbs used for CVA basically do not have same ingredients with only a few expectations, and nearly every herb has targets (targets with blue or purple color) of the disease-related target clusters. By combination of different herbs, more ingredients can collaborate with each other to achieve the same therapeutic effects, for ingredients of different herbs share similar functions.
3.5. Ingredient Network
3.5.1. Ingredient Network Construction
We constructed an ingredient network (Figure 6) to do further analysis of the relationship between herbs and ingredients. The edges of this network were decided by the intersection of the functional items enriched by the targets of two ingredients instead of the intersections of simple targets of two ingredients, because different targets, which can share similar functions by involving in the same processes or different pathways, do not stand for different functions of ingredients.
By construction of ingredient network, not only did we know whether there were interactions between ingredients, but also we obtained the implications of their interactions as partly shown in Table 3. For example, there is an interaction between the ingredients schaftoside and glycyroside, and the targets of two compounds share part of the enriched GOs and pathways, like the GO processes of “cellular aldehyde metabolic process,” GO molecular functions of “alcohol dehydrogenase (NADP+) activity,” and the pathway of “triacylglycerol metabolism p.1.” That is to say, ingredients schaftoside and glycyroside act on the targets with similar functions, in the same biological processes and in the same localizations of human body. Above all, each edge has corresponding functional annotations, which can reveal the interactions of two ingredients, with respect to GO processes, GO molecular functions, and GO localizations and pathways.
3.5.2. Modules of Ingredient Network
Six modules (as shown in Figure 7) were identified from the ingredient network by the MCODE method; each module represents a densely related ingredient set. By visual observation, it is evident to see that ingredients of two types of functions (blue ones and purple ones, resp., act on targets in two disease-related target clusters) are mainly located in different modules.
Since each edge of the network has its corresponding biology items in respect to GO processes, GO molecular functions, and GO localizations and pathways calculated by MetaDrug, that is to say, each interaction has its corresponding biology implications, ingredients of the same module must share certain GOs or pathways. We did analysis of these implications within each module to mine the underlying biology functions of the ingredient set. At last, the main functions of 3 largest modules were given out (as shown in Table 4). Take for example Module 2; most of the ingredients in this module have effects on the targets located in soluble fraction, cell projection, with the molecular functions of regulatory region nucleic acid binding, transcription factor binding, and protein binding, interfere with the processes of developmental process, regulation of cell death, and so on, and act on the main pathway of EGFR signaling pathways, IL-17 signaling pathways, Immune response_C5a signaling, and so on.
To make clear the main functions of the ingredients, we need to consider the three biggest modules. According to the colors of the nodes in these three modules, we can deduce that Module 1 is composed of some ingredients whose targets are in the disease-related target Cluster 5 and some ingredients whose targets are not in the disease-related target clusters, so it achieves therapeutic effects by influencing some processes which can contribute to the disease indirectly. Module 2 and Module 3 are composed of ingredients whose targets are mainly in the disease-related target Cluster 4 and Cluster 5, respectively; consequently they can restore the health state by acting on the disease-related targets.
To be detailed, we did further study and literature survey about the functions of the three main modules in Table 4.
The main function of Module 1 is related to steroid metabolism. In patients with steroid-resistant asthma, reduced steroid responsiveness is related to several molecular mechanisms. Nuclear translocation of glucocorticoid receptor (GR) α after binding corticosteroids is reduced, which might be due to phosphorylation of the GR activated by several kinases (p38 MAPK α, p38 MAPK γ, and c-Jun N-terminal kinase 1). Furthermore, increased expression of GRβ competes with GRα and thus inhibits activated GRα, ultimately leading to steroid resistance. Long-acting β2-agonists can increase steroid responsiveness by reversing phosphorylation of GRα. Testosterone and 5α-dihydrotestosterone caused nuclear localization of 5-lipoxygenase, which initiated the biosynthesis of leukotriene and lipid mediators involved in asthma. Consequently, ingredients in Module 1 can contribute to the cure of asthma by the steroid metabolism.
Ingredients in Module 2 were highly related to immune and inflammation processes and are core module for the therapy of asthma. Among the frequent pathways of Module 2, hyperactivation of EGFR signaling pathway was commonly involved in the mucous hypersecretion and initiated the activation of ERK1/2, PI3K, and Akt kinase in chronic inflammation of the airway . In the pathway of angiotensin signaling via PYK2, PYK2 was essential for inflammatory cell migration and regulated airway inflammation, Th2 cytokine secretion, and airway hyperresponsiveness in the ovalbumin-sensitized mice during antigen challenge . Vascular endothelial growth factor (VEGF) was secreted by human airway smooth muscle cells, and the level of VEGF was elevated by bradykinins through a protein kinase and prostanoid-dependent mechanism . The expression of VEGF and VEGFR in asthma patients increased accompanied by an increased number and size of blood vessels in asthmatic airways . Interleukin-(IL-) 17 may inhibit the induction of tolerance to antigen through inducing IL-6 production, thereby suppressing the expansion of Foxp3-positive regulatory T (Treg) cells . IL-5 is directly involved in recruiting eosinophils to the lung. Once recruited, eosinophils participate in the modulation of immune response, induction of airway hyperresponsiveness, and remodeling in asthma .
Function of module 3 is relevant to ion conduction and transport. The intracellular concentration of free ions regulates many cell functions such as secretion, contraction, motility, and transport processes. Ion channels including K and Ca channels modulated the activity of several structural and inflammatory cells and played an important role in the pathophysiology of asthma. These ion channels might serve as novel targets for the treatment of asthma . Chloride channels are expressed on airway smooth muscle and influence airway smooth muscle force and cell length, which play an important role in the airway smooth muscle contraction and relaxation mechanisms. Activation of the ligand-gated chloride channel GABAA relaxed airway smooth muscle with the tachykinin and substance P. Activation of the glycine receptor was shown to relax airway smooth muscle with a selective neurokinin 2 receptor agonist .
Therefore, it can be inferred that different ingredients in the same module cooperate with each other to achieve certain effects; ingredients within each module act on targets with similar functions and play roles in related pathways. In the meantime, different modules with distinctive functions play different roles in the treatment to achieve overall effects by affecting different biological processes.
In addition, we were also interested in the relationship between modules and herbs, and we got the related herbs for each module as shown in Table 5 by finding out herbs which are connected with the ingredients of the module in the herb-ingredient network (Figure 5). The result suggests that the ingredients of a module are mainly from different herbs. This result, together with the herb-ingredient network, can reveal that although different herbs have distinctive ingredients, they can collaborate with each other through ingredients with similar curative effects.
3.6. The Mechanism of the Treatment of Feature Zhengs Based on the Module Functions
According to the network-based analyses of the ingredients of the key herbs, we infer that ingredients from different herbs can restore the healthy state by influencing multiple targets with different functions, and the ingredients share certain biological functions to collaborate with each other to obtain the therapeutic effects. By further mining the latent biology knowledge from the ingredient-network modules, the mechanism of the treatment of the feature Zhengs “FengXieFanFei,” “FeiQiShiXuan,” and “QiDaoLuanJi” was explained from three aspects.(1)The treatment has effects on the steroid metabolism which play a role in the treatment of asthma.(2)The treatment is highly related to immune and inflammation processes by influencing the pathways of EGFR, VEGF, Gn-RH, IL-17, and so forth, all of which play critical roles in asthma.(3)Regulation of ion conduction and transport, which can promote relaxation of airway smooth muscle and modulate the activity of structural and inflammatory cells, respectively, is another critical part in the treatment for the feature Zhengs.
TCM experts have accumulated many TCM clinical cases which contain meaningful treatment experiences and rules. To uncover the mechanism of treatment of Zhengs, systematical analyses about the clinical cases for patients with CVA have been done. The results can be shown from the following six aspects.(1)The feature Zhengs of CVA are “FengXieFanFei,” “FeiQiShiXuan,” and “QiDaoLuanJi.”(2)Eleven key herbs which not only play key roles by isolation analysis but also cooperate with each other frequently are SAA, Lum, PFL, PC, AGB, AT, FEJ, SC, PFS, RL, and FHE.(3)There are 18 functional clusters based on 372 reliable potential targets which are targeted by more than 7 compounds of the key herbs.(4)An herb-ingredient network was constructed, and we can catch sight of the composition features of herbs from the network. (5)An ingredient network, in which each ingredient was assigned functional items based on the enrichment analyses of potential targets in respect to GOs and pathways, was also constructed. It can present the functional relations of ingredients as well as getting the latent interaction mechanism.(6)Modules of the ingredient network which can show the latent collaboration among ingredients were identified, and main functions of the modules can help to illustrate the mechanism of the key herbs.
Herbal medicine is a complex system which can restore the state of patients back to a health level by influencing multiple bioprocesses . The mechanism of the treatment of Zhengs which is highly related to the key herbs can be explained indirectly by analysis of the corresponding herbs.
In this work, we have discussed the functions of ingredients and targets of the key herbs and identified different target clusters and ingredient modules, which can provide evidence for explanations of the treatment of CVA. Since these key herbs are most commonly used for the treatment of the feature Zhengs “FengXieFanFei,” “FeiQiShiXuan,” and “QiDaoLuanJi,” the mechanism of the treatment of these Zhengs must agree with the actions of these key herbs.
Based on the systematic analyses of key herbs, we have illustrated that the therapeutic effects of “FengXieFanFei,” “FeiQiShiXuan,” and “QiDaoLuanJi” were achieved by ingredients with similar functions in three main aspects as below.(1)The treatment has impacts on the metabolic processes of steroid.(2)The treatment is highly related to the immune and inflammation processes by influencing the pathways of EGFR, VEGF, Gn-RH, IL-17, and so on, all of which play critical roles in asthma.(3)Except for the two main functions above, the treatment also has effects on the regulation of ion conduction and transport.
In general, compared to Western drugs, TCM therapy aims to correct maladjustments and restore the self-regulatory ability of the body by influencing targets with multiple pathogenic effects. This systematical study provides a new conceptual framework for multilevel explanations and scientific understanding for the mechanism of TCM treatment and thus can promote the scientific understanding of TCM theory. However, considering the insufficiency of complete collections of the compositions of herbs and the prediction of targets, the mechanism still requires further rigorous studies.
Conflict of Interests
The authors declare that they do not have a direct financial relation with any commercial identity including the ones mentioned in the paper. None of the authors have a conflict of interests to declare.
Di Chen, Fangbo Zhang, and Shihuan Tang contributed equally to this work.
This work was supported by the Special Research Foundation for Traditional Chinese Medicine (Grant no. 200907001-5), the National Science Foundation for Postdoctoral Scientists of China (Grant no. 2012M510733), and the National Science Foundation of China (Grant no. 81303152).
- P. P. Song, J. J. Gao, N. Kokudo, and W. Tang, “Standardization of traditional Chinese medicine and evaluation of evidence from its clinical practice,” Drug Discoveries & Therapeutics, vol. 5, no. 6, pp. 261–265, 2011.
- L. Guo, Y.-Y. Wang, Z.-B. Zhang, and J.-L. Zhang, “Origination and development of syndrome concept in traditional Chinese medicine,” Zhong Xi Yi Jie He Xue Bao, vol. 4, no. 4, pp. 335–338, 2006.
- Z. B. Zhang and Y. Y. Wang, “Research on TCM syndrome nomenclature and classification: review and hypothesis,” Journal of Beijing University to Traditional Chinese Medicine, vol. 26, no. 2, pp. 1–5, 2003.
- S. Li, “Framework and practice of network-based studies for Chinese herbal formula,” Zhong Xi Yi Jie He Xue Bao, vol. 5, no. 5, pp. 489–493, 2007.
- M. Spinella, “The importance of pharmacological synergy in psychoactive herbal medicines,” Alternative Medicine Review, vol. 7, no. 2, pp. 130–137, 2002.
- B. Li, X. Xu, X. Wang, et al., “A systems biology approach to understanding the mechanisms of action of Chinese herbs for treatment of cardiovascular disease,” International Journal of Molecular Science, vol. 13, no. 10, pp. 13501–13520, 2012.
- B. C. Shin, S. Kim, and Y. H. Cho, “Syndrome pattern and its application in parallel randomized controlled trials,” Chinese Journal of Integrative Medicine, vol. 3, pp. 163–171, 2012.
- W. G. Meng, L. Shi, L. Y. Wu, L. Y. Lai, et al., “Clinical research on treatment of migraine with pine needle moxibustion,” Zhongguo Zhen Jiu, vol. 32, no. 6, pp. 519–522, 2012.
- Y.-H. Zhou, K.-M. Wei, L.-Y. He et al., “Multi-central clinical research into treating 80 cases of chronic thrombocytopenia with qi-supplementing and yin-nourishing therapy and western medicine,” Journal of Traditional Chinese Medicine, vol. 31, no. 4, pp. 277–281, 2011.
- S. Li, “Network systems underlying traditional Chinese medicine syndrome and herb formula,” Current Bioinformatics, vol. 4, no. 3, pp. 188–196, 2009.
- N. Nieto, “A systems biology approach for understanding the collagen regulatory network in alcoholic liver disease,” Liver International, vol. 32, no. 2, pp. 189–198, 2012.
- S. Ekins, Y. Nikolsky, and T. Nikolskaya, “Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity,” Trends in Pharmacological Sciences, vol. 26, no. 4, pp. 202–209, 2005.
- A. Bugrim, T. Nikolskaya, and Y. Nikolsky, “Early prediction of drug metabolism and toxicity: systems biology approach and modeling,” Drug Discovery Today, vol. 9, no. 3, pp. 127–135, 2004.
- S. Ekins, E. Kirillov, E. A. Rakhmatulin, and T. Nikolskaya, “A novel method for visualizing nuclear hormone receptor networks relevant to drug metabolism,” Drug Metabolism and Disposition, vol. 33, no. 3, pp. 474–481, 2005.
- J. Scheiber, B. Chen, M. Milik et al., “Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis,” Journal of Chemical Information and Modeling, vol. 49, no. 2, pp. 308–317, 2009.
- D. Johnson and L. M. Osborn, “Cough variant Asthma: a review of the clinical literature,” Journal of Asthma, vol. 28, no. 2, pp. 85–90, 1991.
- H. Matsumoto, R. P. Tabuena, A. Niimi et al., “Cough triggers and their pathophysiology in patients with prolonged or chronic cough,” Allergology International, vol. 61, no. 1, pp. 123–132, 2012.
- H. Matsumoto, A. Niimi, M. Takemura et al., “Features of cough variant Asthma and classic Asthma during methacholine-induced brochoconstriction: a cross-sectional study,” Cough, vol. 5, no. 1, article 3, 2009.
- J. C. Martínez Alonso, A. Callejo Melgosa, M. J. Fuentes Gonzalo, and C. Martín García, “Rhinitis and Asthma due to ranitidine,” Journal of Investigational Allergology & Clinical Immunology, vol. 16, no. 2, pp. 142–143, 2006.
- P. Sangsupawanich, V. Chongsuvivatwong, L. Mo-Suwan, and C. Choprapawon, “Relationship between atopic dermatitis and wheeze in the first year of life: analysis of a prospective cohort of Thai children,” Journal of Investigational Allergology & Clinical Immunology, vol. 17, no. 5, pp. 292–296, 2007.
- S. W. Christensen, J. P. Bonde, and Ø. Omland, “A prospective study of decline in lung function in relation to welding emissions,” Journal of Occupational Medicine and Toxicology, vol. 3, no. 1, article 6, 2008.
- I. Mohebbi, E. Hassani, S. Salarilak, and A. R. Bahrami, “Do bullae and emphysema increase risk of pneumothorax in silicosis?” Journal of Occupational Medicine and Toxicology, vol. 2, no. 1, article 8, 2007.
- M. Ashburner, C. A. Ball, J. A. Blake et al., “Gene ontology: tool for the unification of biology,” Nature Genetics, vol. 25, no. 1, pp. 25–29, 2000.
- J. Q. Wu, Y. Chen, H. C. Zhang, et al., “Characteristic of therapy used by professor CHAO En-xiang for treatment of pulmonary system diseases,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 22, no. 10, pp. 688–690, 2007.
- Y. L. Li, E. X. Chao, and S. W. L, “Cognition of cough variant Asthma from essence of disease,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 21, no. 12, pp. 780–781, 2006.
- P. Lu, J. Li, S. H. Tang, et al., “Development and application of traditional Chinese medicine inheritance support system,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 18, no. 9, pp. 1–4, 2012.
- S. Yu, Z. Guo, Y. Guan, et al., “Combining ZHENG theory and high-throughput expression data to predict new effects of Chinese herbal formulae,” Evidence Based Complement and Alternative Medicine, vol. 2012, Article ID 986427, 8 pages, 2012.
- S. Li, B. Zhang, D. Jiang, Y. Wei, and N. Zhang, “Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae,” BMC Bioinformatics, vol. 11, no. 11, p. S6, 2010.
- J. Li, R. G. Wu, F. Y. Meng, et al., “Synergism and rules from combination of Baicalin, Jasminoidin and Desoxycholic acid in refined Qing Kai Ling for treat ischemic stroke mice model,” PLoS ONE, vol. 7, no. 9, Article ID e45811, 2012.
- S. Wang, Y. Hu, W. Tan, et al., “Compatibility art of traditional Chinese medicine: from the perspective of herb pairs,” Journal of Ethnopharmacology, vol. 143, no. 2, pp. 412–423, 2012.
- H. Z. Yang and Y. P. Gong, “Progress and thinking on the herb-pairs of Chinese medicine,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 30, no. 2, pp. 218–220, 2010.
- R. Agrawal and R. Srikant, “Fast algorithms for mining association rules,” in Proceedings of the 20th International Conference on Very Large Databases, 1994.
- P. Imming, C. Sinning, and A. Meyer, “Drugs, their targets and the nature and number of drug targets,” Nature Reviews Drug Discovery, vol. 5, no. 10, pp. 821–834, 2006.
- M. A. Lindsay, “Finding new drug targets in the 21st century,” Drug Discovery Today, vol. 10, no. 23-24, pp. 1683–1687, 2005.
- F. Sams-Dodd, “Target-based drug discovery: is something wrong?” Drug Discovery Today, vol. 10, no. 2, pp. 139–147, 2005.
- J. W. Godden, L. Xue, J. Bajorath, et al., “Combinatorial preferences affect molecular similarity/diversity calculations using binary fingerprints and tanimoto coefficients,” Journal of Chemical Information and Computer Sciences, vol. 40, no. 1, pp. 163–166, 2000.
- D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists,” Nucleic Acids Research, vol. 37, no. 1, pp. 1–13, 2009.
- M. E. Smoot, K. Ono, J. Ruscheinski, P.-L. Wang, and T. Ideker, “Cytoscape 2.8: new features for data integration and network visualization,” Bioinformatics, vol. 27, no. 3, pp. 431–432, 2011.
- M. E. J. Newman, “Modularity and community structure in networks,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 23, pp. 8577–8582, 2006.
- M. Girvan and M. E. J. Newman, “Community structure in social and biological networks,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 12, pp. 7821–7826, 2002.
- J. P. Fratkin, “Improved outcomes when combining TCM with western interventions for cancer,” Acupuncture Today, vol. 6, no. 9, p. 205, 2005.
- X. Zheng, X. Zhao, R. Yang, S. Wang, Y. Wei, and J. Zheng, “β2-Adrenoceptor affinity chromatography and its application in the screening of the active compounds from Semen Armeniacae Amarum,” Chinese Science Bulletin, vol. 53, no. 6, pp. 842–847, 2008.
- W. C. W. Wong, A. Lee, A. T. Lam, et al., “Effectiveness of a Chinese herbal medicine preparation in the treatment of cough in uncomplicated upper respiratory tract infection: a randomized double-blinded placedbo-control trail,” Cough, vol. 2, p. 5, 2006.
- S. N. Xu, M. Y. Zhang, Y. M. Wang, et al., “Antitussive, expectorant and antiAsthmatic effects of periostracum cicadae,” Chinese Pharmacological Bulletin, vol. 23, no. 12, pp. 1678–1679, 2008.
- J. H. Chen, Z. H. Xia, and R. X. Tan, “High-performance liquid chromatographic analysis of bioactive triterpenes in Perilla frutescens,” Journal of Pharmaceutical and Biomedical Analysis, vol. 32, no. 6, pp. 1175–1179, 2003.
- J.-H. Ju, L. Zhou, G. Lin, D. Liu, L.-W. Wang, and J.-S. Yang, “Studies on constituents of triterpene acids from Eriobotrya japonica and their anti-inflammatory and antitussive effects,” Zhongguo Yao Xue Za Zhi, vol. 38, no. 10, pp. 752–757, 2003.
- M. Zhu, K. F. Lin, R. Y. Yeung, and R. C. Li, “Evaluation of the protective effects of Schisandra chinensis on Phase I drug metabolism using a CCl4 intoxication model,” Journal of Ethnopharmacology, vol. 67, no. 1, pp. 61–68, 1999.
- C. H. Hsu, C. M. Lu, and T. T. Chang, “Efficacy and safety of modified Mai-Men-Dong-Tang for treatment of allergic Asthma,” Pediatric Allergy and Immunology, vol. 16, no. 1, pp. 76–81, 2005.
- Y. P. Zhang, D. Zhao, L. Lin, et al., “Clinical study on SuHuang ZhiKe capsule in treating 140 cases of cough variant Asthma,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 22, no. 11, pp. 773–776, 2007.
- H. M. Li, X. L. Kang, X. Q. Li, et al., “Studies on antitussive and antiAsthmatic action of suhuangzhike granules,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 14, no. 8, pp. 51–53, 2008.
- Z. D. Zhang, Y. Zhang, K. Q. Deng, et al., “Effect of Suhuangzhike Decoction on immune function in patients with cough variant Asthma,” Journal of Beijing University of Traditional Chinese Medicine, vol. 30, no. 9, pp. 637–639, 2007.
- A. Hamosh, A. F. Scott, J. S. Amberger, C. A. Bocchini, and V. A. McKusick, “Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders,” Nucleic Acids Research, vol. 33, pp. D514–D517, 2005.
- E. A. Townsend, L. W. Meuchel, M. A. Thompson, C. M. Pabelick, and Y. S. Prakash, “Estrogen increases nitric-oxide production in human bronchial epithelium,” Journal of Pharmacology and Experimental Therapeutics, vol. 339, no. 3, pp. 815–824, 2011.
- C. Donovan, X. Tan, and J. E. Bourke, “PPARγ ligands regulate noncontractile and contractile functions of airway smooth muscle: implications for Asthma therapy,” PPAR Research, vol. 2012, Article ID 809164, 13 pages, 2012.
- G. L. Johnson and R. Lapadat, “Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases,” Science, vol. 298, no. 5600, pp. 1911–1912, 2002.
- Y. S. Shin, K. Takeda, Y. Shiraishi et al., “Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation,” American Journal of Respiratory Cell and Molecular Biology, vol. 46, no. 4, pp. 488–497, 2012.
- V.-A. Oxelius, A.-M. Carlsson, and M. Aurivillius, “Alternative G1m, G2m and G3m allotypes of IGHG genes correlate with atonic and nonatopic pathways of immune regulation in children with bronchial Asthma,” International Archives of Allergy and Immunology, vol. 115, no. 3, pp. 215–219, 1998.
- M. M. Marc, P. Korosec, M. Kosnik et al., “Complement factors C3a, C4a, and C5a in chronic obstructive pulmonary disease and Asthma,” American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 2, pp. 216–219, 2004.
- M. van der Deen, E. G. E. de Vries, W. Timens, R. J. Scheper, H. Timmer-Bosscha, and D. S. Postma, “ATP-binding cassette (ABC) transporters in normal and pathological lung,” Respiratory Research, vol. 6, article 59, 2005.
- J. Yang, Q. Li, X. D. Zhou, V. P. Kolosov, and J. M. Perelman, “Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells,” Molecular and Cellular Biochemistry, vol. 351, no. 1-2, pp. 29–40, 2011.
- Y. Duan, J. Learoyd, A. Y. Meliton, B. S. Clay, A. R. Leff, and X. Zhu, “Inhibition of Pyk2 blocks airway inflammation and hyperresponsiveness in a mouse model of Asthma,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 4, pp. 491–497, 2010.
- A. J. Knox, L. Corbett, J. Stocks, E. Holland, Y. M. Zhu, and L. Pang, “Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism,” The FASEB Journal, vol. 15, no. 13, pp. 2480–2488, 2001.
- B. N. Feltis, D. Wignarajah, L. Zheng et al., “Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in Asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 11, pp. 1201–1207, 2006.
- H. Kawakami, T. Koya, H. Kagamu, et al., “IL-17 eliminates therapeutic effects of oral tolerance in murine airway allergic inflammation,” Clinical and Experimental Allergy, vol. 42, no. 6, pp. 946–957, 2012.
- S. S. Possa, E. A. Leick, C. M. Prado, et al., “Eosinophilic inflammation in allergic Asthma,” Frontiers in Pharmacologyogy, vol. 17, no. 4, p. 46, 2013.
- P. Bradding and H. Wulff, “The K+ channels KCa3.1 and Kv1.3 as novel targets for Asthma therapy,” British Journal of Pharmacology, vol. 157, no. 8, pp. 1330–1339, 2009.
- E. A. Townsend, P. D. Yim, G. Gallos, et al., “Can we find better bronchodilators to relieve Asthma symptoms?” Journal of Allergy, vol. 2012, Article ID 321949, 5 pages, 2012.
- C. Wang, Y. Wan, X. Luo et al., “Regulative mechanism of Chinese herbal medicine on cell signaling pathway in kidney,” Zhongguo Zhong Yao Za Zhi, vol. 36, no. 1, pp. 85–91, 2011.